In vitro test systems and their limitations

EXCLI Journal

Volumn 12, Issue , 2013, Pages 1024-1026

  Ghallab, Ahmed ^a  

^a SOUTH VALLEY UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE;

CARCINOGEN TESTING; CELL ISOLATION; CELL TYPE; DETOXIFICATION; DOWN REGULATION; ENZYME MECHANISM; ENZYME METABOLISM; IN VITRO STUDY; IN VIVO STUDY; LETTER; LIVER CELL; LIVER FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; REGULATOR GENE; REPRODUCTIVE TOXICITY; SIGNAL TRANSDUCTION; SKIN SENSITIZATION; TOXICITY TESTING; UPREGULATION; XENOBIOTIC METABOLISM;

EID: 84890394728     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Letter

References (24)

1. Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 2011; 85: 367-485.
2. Bolt HM. Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available. Arch Toxicol 2013; 87: 5-6.
3. Braeuning A, Vetter S, Orsetti S, Schwarz M. Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: What kills the untreated cells? Arch Toxicol 2012; 86: 1481-7.
4. Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol 2011; 85: 723-31.
5. Ghallab A, Henkel S, Driesch D, Hoehme S, Kuepfer L, Zellmer S et al. Integrated spatialtemporal and metabolic modelling identifies the necessity of alpha-ketoglutarate substitution upon acute liver damage. 2014, in prep.
6. Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Müller A et al. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor betainduced apoptosis. Hepatology 2009; 49: 2031-43.
7. Godoy P, Schug M, Bauer A, Hengstler JG: Reversible manipulation of apoptosis sensitivity in cultured hepatocytes by matrix-mediated manipulation of signaling activities. Methods Mol Biol 2010a; 640: 139-55.
8. Godoy P, Lakkapamu S, Schug M, Bauer A, Stewart JD, Bedawi E et al. Dexamethasone-dependent versus-independent markers of epithelial to mesenchymal transition in primary hepatocytes. Biol Chem 2010b; 391: 73-83.
9. Hammad S. Advances in 2D and 3D in vitro systems for hepatotoxicity testing. EXCLI J 2013; 12: 993-6.
10. Hoehme S, Brulport M, Bauer A, Bedawy E, Schormann W, Hermes M et al. Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc Natl Acad Sci U S A 2010; 107: 10371-6.
11. Knobeloch D, Ehnert S, Schyschka L, Büchler P, Schoenberg M, Kleeff J et al. Human hepatocytes: isolation, culture, and quality procedures. Methods Mol Biol 2012; 806: 99-120.
12. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 2012; 86(7): 1123-36.
13. Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, Meganathan K et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 2013; 87: 123-43.
14. Lee MJ, Ayaki H, Goji J, Kitamura K, Nishio H. Cadmium restores in vitro splicing activity inhibited by zinc-depletion. Arch Toxicol 2006; 80: 638-43.
15. Liebsch M, Grune B, Seiler A, Butzke D, Oelgeschläger M, Pirow R et al. Alternatives to animal testing: current status and future perspectives. Arch Toxicol 2011; 85: 841-58.
16. Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R et al. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch Toxicol 2008; 82: 211-36.
17. Meyer C, Godoy P, Bachmann A, Liu Y, Barzan D, Ilkavets I et al. Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes. J Hepatol 2011; 55: 369-78.
18. Schliess F, Hoehme S, Henkel S, Ghallab A, Driesch D, Böttger J et al. Integrated metabolic spatialtemporal models for prediction of ammonia metabolism during liver damage and regeneration. Hepatology 2013, in revision.
19. Schug M, Stöber R, Heise T, Mielke H, Gundert-Remy U, Godoy P et al. Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes. Arch Toxicol 2013; 87: 337-45.
20. Sogorb MA, Alvarez-Escalante C, Carrera V, Vilanova E. An in vitro approach for demonstrating the critical role of serum albumin in the detoxication of the carbamate carbaryl at in vivo toxicologically relevant concentrations. Arch Toxicol 2007; 81: 113-9.
21. Tice RR, Austin CP, Kavlock RJ, Bucher JR. Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 2013; 121: 756-65.
22. Valente MJ, Henrique R, Vilas-Boas V, Silva R, Bastos Mde L, Carvalho F et al. Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells. Arch Toxicol 2012; 86: 249-61.
23. Vávrová A, Popelová O, Stěrba M, Jirkovský E, Hašková P, Mertlíková-Kaiserová H et al. In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. Arch Toxicol. 2011 May; 85(5): 525-35. doi: 10. 1007/s00204-010-0615-8.
24. Zellmer S, Schmidt-Heck W, Godoy P, Weng H, Meyer C, Lehmann T et al. Transcription factors ETF, E2F, and SP-1 are involved in cytokineindependent proliferation of murine hepatocytes. Hepatology 2010; 52: 2127-36.